why choose us

First received: March 11, 2026

Clinical Trial: A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Cardiomyopathy

Study Type: INTERVENTIONAL


Official Title: A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants

Brief Summary: This study will investigate the bioequivalence between two formulations of HRS-1893 tablets. Safety and tolerability will also be assessed.

Read more